StudyGraphics #VisualAbstract: Circulating tumor DNA levels may predict treatment response in patients with advanced melanoma March 11, 2021 | Teddy Guo Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Click to read the study in The Lancet Oncology. RELATED ARTICLESMORE FROM AUTHOR #Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas #VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas #VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas
